Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF 10A
NM
Basal B
FR180204
ERK1/2
MAPK
11056.149
uM
49.1670
47.38650
0.8659 0.0842 4.9997 0.0119
0.6025
2.9204
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
7814.042
uM
1.1580
1.97410
0.7528 -0.7381 1.6997 0.0120
0.7787
0.8414
ZR75B
HR+
Luminal
Erlotinib
EGFR
ErbB
7555.091
uM
222.88850
687.59880
0.7916 -0.8665 0.8924 0.0120
0.8409
1.6040
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
7856.018
uM
inf
inf
0.8811 0.8811 0.0000 0.0121
0.4683
0.9388
MDA-MB-231
TNBC
Basal B
Cetuximab
EGFR
ErbB
7892.018
uM
inf
0.5010
0.8331 0.7197 1.2256 0.0122
0.8070
2.4903
BT-549
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
9024.016
uM
inf
5.49290
0.9158 0.9125 0.9479 0.0127
0.6896
3.2430
MDA-MB-157
TNBC
Basal B
Purvalanol A
CDK1
CDK
7498.067
uM
inf
284.49690
0.8398 0.5893 0.8420 0.0128
0.7609
1.1346
HCC38
TNBC
Basal B
AG1024
IGF1R
RTK
7469.066
uM
inf
inf
0.9727 0.9727 0.0000 0.0128
-0.0529
2.0057
MB 157
Unknown
Unknown
PD 98059
MEK
MAPK
12580.152
uM
inf
13.27340
0.8145 0.8142 4.7549 0.0130
0.9491
2.2597
HCC1395
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7436.095
uM
inf
inf
0.9643 0.9643 0.0000 0.0131
0.0000
1.3597
HCC1937
TNBC
Basal A
Dichloroacetate
PDK
PDK
13115.176
uM
inf
0.22160
0.8209 0.8738 5.0000 0.0131
0.6538
0.8197
BT-549
TNBC
Basal B
L-779450
BRAF
MAPK
12305.166
uM
50.02890
43.34140
0.8426 0.2560 4.9997 0.0132
0.6646
2.9556
MDA-MB-157
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7498.098
uM
inf
22.53420
0.8724 0.7240 0.6002 0.0132
0.6801
1.1057
MCF 10F
NM
-
Ribavirin
15393.211
uM
inf
inf
0.8354 0.8354 0.0000 0.0133
0.5287
1.6449
MDA-MB-415
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
7511.073
uM
inf
52.84510
0.6306 0.6292 4.8844 0.0134
0.9407
1.0909
ZR75B
HR+
Luminal
Cetuximab
EGFR
ErbB
9972.125
uM
4.30080
14.18760
0.8594 -0.8482 0.8310 0.0135
0.6892
1.1854
HCC3153
TNBC
Basal A
Nilotinib
ABL
nRTK
10937.145
uM
inf
inf
1.0433 1.0433 0.0000 0.0136
0.0664
1.2098
SUM159PT
TNBC
Basal B
Purvalanol A
CDK1
CDK
7531.067
uM
inf
34.52310
0.8619 0.8619 5.0000 0.0137
0.8457
3.6061
184B5
NM
Basal
Cisplatin
DNA cross-linker
DNA cross-linker
9095.049
uM
inf
193.58440
0.7160 0.7080 3.7384 0.0137
0.8937
1.1202
T47DKBLUC
Unknown
Unknown
Erlotinib
EGFR
ErbB
7544.092
uM
inf
inf
0.9208 0.9208 0.0000 0.0137
-0.0102
1.1147
SK-BR-3
HER2amp
Luminal
AG1024
IGF1R
RTK
7526.066
uM
165.54090
435.63610
0.8376 -0.6562 0.8664 0.0138
0.850
1.5937
MCF7
HR+
Luminal
Ixabepilone
TUBB
TUBB
7492.095
uM
inf
inf
0.9180 0.9180 0.0000 0.0139
0.0229
1.0194
T47DKBLUC
Unknown
Unknown
Nelfinavir
13070.174
uM
inf
inf
1.0500 1.0500 0.0000 0.0140
0.0000
0.7993
MB 157
Unknown
Unknown
PS-1145
IKK
NFKB
7482.065
uM
inf
inf
0.9413 0.9413 0.0000 0.0141
0.0523
2.2390
HCC3153
TNBC
Basal A
L-779450
BRAF
MAPK
10577.137
uM
128.91780
407.61850
0.8182 -0.9196 0.9065 0.0143
0.7373
0.9653